Skip to main content

2025 IDWeek Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

65 Views

A2. PK/PD studies

Poster Session: PK/PD Studies

(P-1245) An Open-Label Phase 1 Study to Evaluate the Effect of Multiple Doses of Rifabutin on the Single-Dose Pharmacokinetics of Ulonivirine in Adults without HIV

Tuesday, October 21, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

Makeda Robinson, MD, PhD

Clinical Director
Merck & Co., Inc.
South San Francisco, CA, United States

Co-Author(s)

RM

Randolph P. Matthews, MD, PhD

Merck & Co., Inc.
Rahway, New Jersey, United States
BK

Bhargava Kandala, PhD

Merck & Co., Inc.
Rahway, New Jersey, United States
AC

Akshita Chawla, PhD

Merck & Co., Inc.
Kenilworth, New Jersey, United States
AB

Arinjita Bhattacharyya, PhD

Merck & Co., Inc.
Rahway, New Jersey, United States
CC

Carol Cannon, MSN

Merck & Co., Inc.
Rahway, New Jersey, United States
AS

Andrea Schaeffer, MS

Merck & Co., Inc.
Rahway, New Jersey, United States
AH

Allen Hunt, MD

Celerion
Lincoln, Nebraska, United States
SS

S. Aubrey Stoch, MD

Merck & Co., Inc.
Kenilworth, New Jersey, United States
JN

Jesse C. Nussbaum, MD

Merck & Co., Inc.
Rahway, New Jersey, United States